These results are not consistent with gossypol acting as a glycolytic inhibitor, but rather as having an uncoupler-like effect on the cell leading to subsequent cell lysis and death. The predominantly glycolytic nature of tumour cells, even under conditions of high oxygen tension (Eigenbrodt et al., 1985) , would be likely to make tumours less sensitive than host tissue to gossypol cytotoxicity. Thus these results do not correlate with the proposal that gossypol has a role in chemotherapy.
Benz, C., Hollander, C., Keniry, M., James , 1 980q b) . It is probable that the majority of these observations represents the effect(s) of cellular ageing, as opposed to a primary cause or causes. However, recent evidence indicates the existence of a highly significant shift to glycolysis with increasing cell population doubling (CPD) which may be of central importance in the ageing process (Bittles & Harper, 1984) . To further investigate this phenomenon, HDF were cultured at five stages during their lifespan in vitro in the presence of the glycolytic inhibitor 2-deoxyglucose and the relative cell yields at each of the CPD were determined. Human embryonic lung fibroblasts, strain 2002 (Flow Labs), were routinely cultured in minimal essential medium (Glasgow modification) containing penicillin ( 100 units/l), streptomycin ( 1 10 pg/l) and supplemented with 10% (v/v) fetal bovine serum (Gibco BRL). The lifespan of this cell strain previously was determined as 6 0 k 3 CPD. For the growth studies, conducted at CPD 23, 33, 43, 53 and 61, HDF were seeded into microtitre plates (Nunc) at a density of approximately 2.7 x lo3 cells per well. Filter-sterilized 2-deoxyglucose (Sigma; final concentrations 1. 3 and 10 mM) was added to the growth medium immediately before commencement of the cultures. Cell yields were estimated directly in the microtitre plates as total cell protein, by solubilization with Triton X-100 and a Coomassie Brilliant Blue dye-binding method (Bio-Rad), daily over a 1 week incubation period. All assays were conducted as tenfold replicates, with seven plates used per CPD.
BIOCHEMICAL SOCIETY TRANSACTIONS
Markedly different growth patterns were observed in the control cells (no 2-deoxyglucose) with increasing CPD (Table  1) . From CPD 23 to 43 there was a slight lengthening of the initial leg phase before onset of the logarithmic phase of growth; however, by CPD 5 3 the lag phase had extended to 3 days and by CPD 6 1 to 4 days. This was paralleled by significant, age-related reductions in total cell yield. Between CPD 23 and 43 the cell yield, measured on day 7, declined by only 10.4%, but by CPD 53 the decrease was 62.7% and 85.4% by CPD 6 1 (measured on day 6.)
Incorporation of 2-deoxyglucose (10 mM) into the growth medium significantly reduced cell yields in the younger cultures: by 67.1% (CPD 23), 86.4% (CPD 33) and 94.7% (CPD 43) . Despite the poor growth characteristics of the older cells a marked inhibitory effect was still apparent at CPD 53 (75.7%) and CPD 6 1 (24.8%). Similar, but less pronounced, patterns of inhibition were obtained at the lower concentrations (1 mM and 3 mM) of 2-deoxyglucose tested (results not shown).
A decline in growth potential after prolonged culture in vitro is a consistent feature of many different human cell types (reviewed in Bittles & Sambuy, 1986) . Attention has been drawn to an apparent critical point in H D F cultures, at approximately CPD 45, beyond which there are increased numbers of non-dividing cells (Macieira-Coelho & Taboury, 1982) , the onset of changes in nucleoprotein organization (Puvion-Dutilleul et al., 1982) and eventually, altered organelle structure and function (Johnson, 1984) . The marked increase in cellular sensitivity to 2-deoxyglucose between CPD 2 3 and 43 in the present study confirms the previous observation of an early shift to glycolysis in HDF (Bittles & Harper, 1984) . Significantly, this enhanced utilization of the glycolytic pathway both precedes and appears independent of the alterations in mitochondria1 structure (Ghadiminejad et al., 1987) and enzyme activity (Harper et al., 1987) characteristic of cells at advanced CPD.
